PriaXplore® increased innovation and efficiency in drug R&D

PriaXplore® was a technology suite that applied computational approaches, combined with complex synthetic chemistry to address thus far intractable molecular interactions of relevance in human health and disease with small molecule based therapies.

It was of note that Priaxplore® was not limited by company IP/ USP on defined areas of chemical space (e.g. “macrocycle companies”), assay technology (e.g. target specific proprietary PPI assay companies) or manufacturing capabilities (linkers, staplers, etc), and thus provides maximal freedom in the selection of targets, chemotypes and assays.